Cutaneous leishmaniasis in the returning traveler

Infectious Disease Clinics of North America

Volumn 19, Issue 1, 2005, Pages 241-266

  Magill, Alan J ^a,b  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY DERIVATIVE; FLUCONAZOLE; ITRACONAZOLE; KETOCONAZOLE; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

ANOREXIA; CLINICAL FEATURE; CLINICAL TRIAL; DISEASE TRANSMISSION; EPIGASTRIC PAIN; FATIGUE; GASTROINTESTINAL TOXICITY; HEADACHE; HUMAN; JOINT STIFFNESS; LEISHMANIA; LEISHMANIA MAJOR; LEISHMANIA PANAMENSIS; LEISHMANIA TROPICA; MUSCULOSKELETAL DISEASE; NAUSEA; PANCREATITIS; REVIEW; SIDE EFFECT; SKIN LEISHMANIASIS; VOMITING;

EID: 13444273287     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.11.005     Document Type: Review

References (128)

1. A. Magill Leishmaniasis S.G. Thomas Hunter's tropical medicine and emerging infectious diseases 8th edition 2000 WB Saunders Philadelphia 665 687
2. R. Reithinger, M. Mohsen, and K. Aadil Anthroponotic cutaneous leishmaniasis, Kabul, Afghanistan Emerg Infect Dis 9 2003 727 729
3. R.L. Jacobson Leishmania tropica (kinetoplastida: trypanosomatidae): a perplexing parasite Folia Parasitol (Praha) 50 2003 241 250
4. M. Tibayrenc, and F.J. Ayala Evolutionary genetics of Trypanosoma and Leishmania Microbes Infect 1 1999 465 472
5. R.D. Kreutzer, N. Souraty, and M.E. Semko Biochemical identities and differences among Leishmania species and subspecies Am J Trop Med Hyg 36 1987 22 32
6. A.L. Banuls, R. Jonquieres, and F. Guerrini Genetic analysis of leishmania parasites in Ecuador: are Leishmania (V.) panamensis and Leishmania (V.) guyanensis distinct taxa? Am J Trop Med Hyg 61 1999 838 845
7. J. Nakayama, T. Matsumoto, and M. Asahi Imported cutaneous leishmaniasis in Japan Int J Dermatol 29 1990 670 672
8. T.D. Naotunne, S. Rajakulendran, and W. Abeywickreme Cutaneous leishmaniasis in Sri Lanka: an imported disease linked to the Middle East and African employment boom Trop Geogr Med 42 1990 72 74
9. W.R. Faber, M. Becht, and C.J. van Ginkel Cutaneous leishmaniasis in 49 patients in The Netherlands Ned Tijdschr Geneeskd 135 1991 229 233
10. P.C. Melby, R.D. Kreutzer, and D. McMahon-Pratt Cutaneous leishmaniasis: review of 59 cases seen at the National Institutes of Health Clin Infect Dis 15 1992 924 937
11. B.L. Herwaldt, S.L. Stokes, and D.D. Juranek American cutaneous leishmaniasis in US travelers Ann Intern Med 118 1993 779 784
12. P. Viriyavejakul, C. Viravan, and M. Riganti Imported cutaneous leishmaniasis in Thailand Southeast Asian J Trop Med Public Health 28 1997 558 562
13. G.P. Maguire, I. Bastian, and S. Arianayagam New World cutaneous leishmaniasis imported into Australia Pathology 30 1998 73 76
14. A. Zlotogorski, L. Gilead, and F. Jonas South American cutaneous leishmaniasis: report of ten cases in Israeli travelers J Eur Acad Dermatol Venereol 11 1998 32 36
15. H.H. Tan, S.S. Wong, and B.H. Ong Cutaneous leishmaniasis: a report of two cases seen at a tertiary dermatological centre in Singapore Singapore Med J 41 2000 179 181
16. G. Harms, G. Schonian, and H. Feldmeier Leishmaniasis in Germany Emerg Infect Dis 9 2003 872 875
17. A. Scope, H. Trau, and G. Anders Experience with New World cutaneous leishmaniasis in travelers J Am Acad Dermatol 49 2003 672 678
18. L. El Hajj, M. Thellier, and J. Carriere Localized cutaneous leishmaniasis imported into Paris: a review of 39 cases Int J Dermatol 43 2004 120 125
19. S. Martin, J. Gambel, and J. Jackson Leishmaniasis in the United States military Mil Med 163 1998 801 807
20. P.J. Wiena, R.C. Neafie, and G. Wortmann Old World leishmaniasis: an emerging infection among deployed US military and civilian workers Clin Infect Dis 39 2004 1674 1680
21. Update: cutaneous leishmaniasis in US military personnel - Southwest/Central Asia, 2002-2004 MMWR Morb Mortal Wkly Rep 53 2004 264 265
22. Two cases of visceral leishmaniasis in US military personnel - Afghanistan, 2002-2004 MMWR Morb Mortal Wkly Rep 53 2004 265 268
23. B.L. Herwaldt, B.A. Arana, and T.R. Navin The natural history of cutaneous leishmaniasis in Guatemala J Infect Dis 165 1992 518 527
24. R. Kubba, Y. Al-Gindan, and A.M. el-Hassan Clinical diagnosis of cutaneous leishmaniasis (oriental sore) J Am Acad Dermatol 16 1987 1183 1189
25. Y. Dowlati Cutaneous leishmaniasis: clinical aspect Clin Dermatol 14 1996 425 431
26. Y. al-Gindan, R. Kubba, and A.M. el-Hassan Dissemination in cutaneous leishmaniasis. 3. Lymph node involvement Int J Dermatol 28 1989 248 254
27. Q. Sousa Ade, M.E. Parise, and M.M. Pompeu Bubonic leishmaniasis: a common manifestation of Leishmania (Viannia) braziliensis infection in Ceara, Brazil Am J Trop Med Hyg 53 1995 380 385
28. A. Barral, J. Guerreiro, and G. Bomfim Lymphadenopathy as the first sign of human cutaneous infection by Leishmania braziliensis Am J Trop Med Hyg 53 1995 256 259
29. L.C. Lucchina, M.E. Wilson, and L.A. Drake Dermatology and the recently returned traveler: infectious diseases with dermatologic manifestations Int J Dermatol 36 1997 167 181
30. M.E. Wilson Skin problems in the traveler Infect Dis Clin North Am 12 1998 471 488
31. A. Mahe Bacterial skin infections in a tropical environment Curr Opin Infect Dis 14 2001 123 126
32. J.P. Willems, S.M. Schmidt, and K.E. Greer Sporotrichoid cutaneous leishmaniasis in a traveler South Med J 90 1997 325 327
33. S.P. Agudelo, S. Restrepo, and I.D. Velez Cutaneous New World leishmaniasis-sporotrichosis coinfection: report of 3 cases J Am Acad Dermatol 40 6 Pt 1 1999 1002 1004
34. T.R. Navin, F.E. Arana, and A.M. de Merida Cutaneous leishmaniasis in Guatemala: comparison of diagnostic methods Am J Trop Med Hyg 42 1990 36 42
35. K.A. Weigle, M. de Davalos, and P. Heredia Diagnosis of cutaneous and mucocutaneous leishmaniasis in Colombia: a comparison of seven methods Am J Trop Med Hyg 36 1987 489 496
36. P.D. Marsden Clinical presentations of Leishmania braziliensis braziliensis Parasitol Today 1 1985 129 133
37. P.D. Marsden Mucosal leishmaniasis due to Leishmania (Viannia) braziliensis L(V)b in Tres Bracos, Bahia-Brazil Rev Soc Bras Med Trop 27 1994 93 101
38. J.T. Zajtchuk, J.D. Casler, and E.M. Netto Mucosal leishmaniasis in Brazil Laryngoscope 99 1989 925 939
39. P.D. Marsden Mucosal leishmaniasis ("espundia" Escomel, 1911) Trans R Soc Trop Med Hyg 80 1986 859 876
40. E.A. Llanos Cuentas, C.C. Cuba, and A.C. Barreto Clinical characteristics of human Leishmania braziliensis braziliensis infections Trans R Soc Trop Med Hyg 78 1984 845 846
41. L.E. Osorio, C.M. Castillo, and M.T. Ochoa Mucosal leishmaniasis due to Leishmania (Viannia) panamensis in Colombia: clinical characteristics Am J Trop Med Hyg 59 1998 49 52
42. R.E. Saenz, H.M. Paz, and G.C. de Rodriguez Mucocutaneous leishmaniasis in Panama: etiologic agent, epidemiologic and clinical aspects Rev Med Panama 14 1989 6 15
43. R.D. Naiff, S. Talhari, and T.V. Barrett Isolation of Leishmania guyanensis from lesions of the nasal mucosa Mem Inst Oswaldo Cruz 83 1988 529 530
44. C. Santrich, I. Segura, and A.L. Arias Mucosal disease caused by Leishmania braziliensis guyanensis Am J Trop Med Hyg 42 1990 51 55
45. C.M. Lucas, E.D. Franke, and M.I. Cachay Geographic distribution and clinical description of leishmaniasis cases in Peru Am J Trop Med Hyg 59 1998 312 317
46. T.C. Jones, W.D. Johnson Jr., and A.C. Barretto Epidemiology of American cutaneous leishmaniasis due to Leishmania braziliensis braziliensis J Infect Dis 156 1987 73 83
47. J. Blum, T. Junghanss, and C. Hatz Erroneous tracks in the diagnosis of cutaneous and mucocutaneous leishmaniasis Schweiz Rundsch Med Prax 83 1994 1025 1029
48. J.L. Rosbotham, E.L. Corbett, and H.R. Grant Imported mucocutaneous leishmaniasis Clin Exp Dermatol 21 1996 288 290
49. P.J. Lohuis, M.M. Lipovsky, and A.I. Hoepelman Leishmania braziliensis presenting as a granulomatous lesion of the nasal septum mucosa J Laryngol Otol 111 1997 973 975
50. A. Scope, H. Trau, and M. Bakon Imported mucosal leishmaniasis in a traveler Clin Infect Dis 37 2003 e83 e87
51. J.W. Costa Jr., D.A. Milner Jr., and J.H. Maguire Mucocutaneous leishmaniasis in a US citizen Oral Surg Oral Med Oral Pathol Oral Radiol Endod 96 2003 573 577
52. S. Ahluwalia, S.D. Lawn, and J. Kanagalingam Mucocutaneous leishmaniasis: an imported infection among travellers to central and South America BMJ 329 2004 842 844
53. C. Singer, D. Armstrong, and T.C. Jones Imported mucocutaneous leishmaniasis in New York City: report of a patient treated with amphotericin B Am J Med 59 1975 444 447
54. P. Galioto, and V. Fornaro A case of mucocutaneous leishmaniasis Ear Nose Throat J 81 2002 46 48
55. M.A. Marovich, R. Lira, and M. Shepard Leishmaniasis recidivans recurrence after 43 years: a clinical and immunologic report after successful treatment Clin Infect Dis 33 2001 1076 1079
56. T.R. Navin, B.A. Arana, and F.E. Arana Placebo-controlled clinical trial of sodium stibogluconate (Pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala J Infect Dis 165 1992 528 534
57. M.E. Ibrahim, D.A. Evans, and T.G. Theander Diversity among Leishmania isolates from the Sudan: isoenzyme homogeneity of L. donovani versus heterogeneity of L. major Trans R Soc Trop Med Hyg 89 1995 366 369
58. S.M. Le Blancq, L.F. Schnur, and W. Peters Leishmania in the Old World: 1. The geographical and hostal distribution of L. major zymodemes Trans R Soc Trop Med Hyg 80 1986 99 112
59. C. Kebaier, H. Louzir, and M. Chenik Heterogeneity of wild Leishmania major isolates in experimental murine pathogenicity and specific immune response Infect Immun 69 2001 4906 4915
60. A. Gaafar, A. Fadl, and A.Y. el Kadaro Sporotrichoid cutaneous leishmaniasis due to Leishmania major of different zymodemes in the Sudan and Saudi Arabia: a comparative study Trans R Soc Trop Med Hyg 88 1994 552 554
61. S.M. Le Blancq, and W. Peters Leishmania in the Old World: 2. Heterogeneity among L. tropica zymodemes Trans R Soc Trop Med Hyg 80 1986 113 119
62. G. Wortmann, R.S. Miller, and C. Oster A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasisin United States military personnel Clin Infect Dis 35 2002 261 267
63. J. Blum, P. Desjeux, and E. Schwartz Treatment of cutaneous leishmaniasis among travellers J Antimicrob Chemother 53 2004 158 166
64. S. Uzun, C. Uslular, and A. Yucel Cutaneous leishmaniasis: evaluation of 3,074 cases in the Cukurova region of Turkey Br J Dermatol 140 1999 347 350
65. O. al-Majali, H.B. Routh, and O. Abuloham A 2-year study of liquid nitrogen therapy in cutaneous leishmaniasis Int J Dermatol 36 1997 460 462
66. J.D. Berman, and F.A. Neva Effect of temperature on multiplication of Leishmania amastigotes within human monocyte-derived macrophages in vitro Am J Trop Med Hyg 30 1981 318 321
67. T.R. Navin, B.A. Arana, and F.E. Arana Placebo-controlled clinical trial of meglumine antimonate (glucantime) vs. localized controlled heat in the treatment of cutaneous leishmaniasis in Guatemala Am J Trop Med Hyg 42 1990 43 50
68. J. El-On, L. Weinrauch, and R. Livshin Topical treatment of recurrent cutaneous leishmaniasis with ointment containing paromomycin and methylbenzethonium chloride BMJ 291 1985 704 705
69. L. Weinrauch, M. Katz, and J. El-On Leishmania aethiopica: topical treatment with paromomycin and methylbenzethonium chloride ointment J Am Acad Dermatol 16 1987 1268 1270
70. J. El-On, R. Livshin, and Z. Even-Paz Topical treatment of cutaneous leishmaniasis J Invest Dermatol 87 1986 284 288
71. J. El-On, R. Livshin, and Z.E. Paz Topical treatment of cutaneous leishmaniasis BMJ 291 1985 1280 1281
72. O. Ozgoztasi, and I. Baydar A randomized clinical trial of topical paromomycin versus oral ketoconazole for treating cutaneous leishmaniasis in Turkey Int J Dermatol 36 1997 61 63
73. L. Weinrauch, F. Cawich, and P. Craig Topical treatment of New World cutaneous leishmaniasis in Belize: a clinical study J Am Acad Dermatol 29 1993 443 446
74. B.A. Arana, C.E. Mendoza, and N.R. Rizzo Randomized, controlled, double-blind trial of topical treatment of cutaneous leishmaniasis with paromomycin plus methylbenzethonium chloride ointment in Guatemala Am J Trop Med Hyg 65 2001 466 470
75. A.D. Bryceson, A. Murphy, and A.H. Moody Treatment of Old World cutaneous leishmaniasis with aminosidine ointment: results of an open study in London Trans R Soc Trop Med Hyg 88 1994 226 228
76. R.X. Armijos, M.M. Weigel, and M. Calvopina Comparison of the effectiveness of two topical paromomycin treatments versus meglumine antimoniate for New World cutaneous leishmaniasis Acta Trop 91 2004 153 160
77. A. Asilian, T. Jalayer, and M. Nilforooshzadeh Treatment of cutaneous leishmaniasis with aminosidine (paromomycin) ointment: double-blind, randomized trial in the Islamic Republic of Iran Bull World Health Organ 81 2003 353 359
78. T. Bogenrieder, N. Lehn, and M. Landthaler Treatment of Old World cutaneous leishmaniasis with intralesionally injected meglumine antimoniate using a Dermojet device Dermatology 206 2003 269 272
79. S. Uzun, M. Durdu, and G. Culha Clinical features, epidemiology, and efficacy and safety of intralesional antimony treatment of cutaneous leishmaniasis: recent experience in Turkey J Parasitol 90 2004 853 859
80. R.E. Kellum Treatment of cutaneous leishmaniasis with an intralesional antimonial drug (Pentostam) J Am Acad Dermatol 15 4 Pt 1 1986 620 622
81. R.M. Faris, J.S. Jarallah, and T.A. Khoja Intralesional treatment of cutaneous leishmaniasis with sodium stibogluconate antimony Int J Dermatol 32 1993 610 612
82. K.E. Sharquie, R.A. Najim, and I.B. Farjou A comparative controlled trial of intralesionally-administered zinc sulphate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis Clin Exp Dermatol 22 1997 169 173
83. K.E. Sharquie, K.K. Al-Talib, and A.C. Chu Intralesional therapy of cutaneous leishmaniasis with sodium stibogluconate antimony Br J Dermatol 119 1988 53 57
84. T.M. Tallab, K.A. Bahamdam, and S. Mirdad Cutaneous leishmaniasis: schedules for intralesional treatment with sodium stibogluconate Int J Dermatol 35 1996 594 597
85. M.A. el Darouti, and S.M. al Rubaie Cutaneous leishmaniasis: treatment with combined cryotherapy and intralesional stibogluconate injection Int J Dermatol 29 1990 56 59
86. A. Asilian, A. Sadeghinia, and G. Faghihi Comparative study of the efficacy of combined cryotherapy and intralesional meglumine antimoniate (Glucantime) vs. cryotherapy and intralesional meglumine antimoniate (Glucantime) alone for the treatment of cutaneous leishmaniasis Int J Dermatol 43 2004 281 283
87. R.E. Saenz, H. Paz, and J.D. Berman Efficacy of ketoconazole against Leishmania braziliensis panamensis cutaneous leishmaniasis Am J Med 89 1990 147 155
88. R. Salmanpour, F. Handjani, and M.K. Nouhpisheh Comparative study of the efficacy of oral ketoconazole with intra-lesional meglumine antimoniate (Glucantime) for the treatment of cutaneous leishmaniasis J Dermatolog Treat 12 2001 159 162
89. J. Dogra, N. Aneja, and B.B. Lal Cutaneous leishmaniasis in India: clinical experience with itraconazole (R51 211 Janssen) Int J Dermatol 29 1990 661 662
90. J. Dogra, and V.N. Saxena Itraconazole and leishmaniasis: a randomised double-blind trial in cutaneous disease Int J Parasitol 26 1996 1413 1415
91. A.Z. Momeni, T. Jalayer, and M. Emamjomeh Treatment of cutaneous leishmaniasis with itraconazole: randomized double-blind study Arch Dermatol 132 1996 784 786
92. J. Soto-Mancipe, M. Grogl, and J.D. Berman Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia Clin Infect Dis 16 1993 417 425
93. A.A. Alrajhi, E.A. Ibrahim, and E.B. De Vol Fluconazole for the treatment of cutaneous leishmaniasis caused by Leishmania major N Engl J Med 346 2002 891 895
94. D.K. Kochar, S. Aseri, and B.V. Sharma The role of rifampicin in the management of cutaneous leishmaniasis QJM 93 2000 733 737
95. R. Livshin, L. Weinrauch, and Z. Even-Paz Efficacy of rifampicin and isoniazid in cutaneous leishmaniasis Int J Dermatol 26 1987 55 59
96. T.Z. Do Valle, M.P. Oliveira Neto, and A. Schubach New World tegumentar leishmaniasis: chemotherapeutic activity of rifampicin in humans and experimental murine model Pathol Biol (Paris) 43 1995 618 621
97. J. Dogra A double-blind study on the efficacy of oral dapsone in cutaneous leishmaniasis Trans R Soc Trop Med Hyg 85 1991 212 213
98. J. Dogra, B.B. Lal, and S.N. Misra Dapsone in the treatment of cutaneous leishmaniasis Int J Dermatol 25 1986 398 400
99. L.E. Osorio, R. Palacios, and M.E. Chica Treatment of cutaneous leishmaniasis in Colombia with dapsone Lancet 351 1998 498 499
100. K.E. Sharquie, R.A. Najim, and I.B. Farjou Oral zinc sulphate in the treatment of acute cutaneous leishmaniasis Clin Exp Dermatol 26 2001 21 26
101. S. Martinez, M. Gonzalez, and M.E. Vernaza Treatment of cutaneous leishmaniasis with allopurinol and stibogluconate Clin Infect Dis 24 1997 165 169
102. S. Martinez, and J.J. Marr Allopurinol in the treatment of American cutaneous leishmaniasis N Engl J Med 326 1992 741 744
103. R.H. Guderian, M.E. Chico, and M.D. Rogers Placebo controlled treatment of Ecuadorian cutaneous leishmaniasis Am J Trop Med Hyg 45 1991 92 97
104. R.A. Seaton, J. Morrison, and I. Man Out-patient parenteral antimicrobial therapy: a viable option for the management of cutaneous leishmaniasis QJM 92 1999 659 667
105. N.E. Aronson, G.W. Wortmann, and S.C. Johnson Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent US military experience Clin Infect Dis 27 1998 1457 1464
106. R.A. Gasser Jr., A.J. Magill, and C.N. Oster Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis Clin Infect Dis 18 1994 83 90
107. G.W. Wortmann, S.L. Fraser, and N.E. Aronson Failure of amphotericin B lipid complex in the treatment of cutaneous leishmaniasis Clin Infect Dis 26 1998 1006 1007
108. M.G. Mendonca, M.E. de Brito, and E.H. Rodrigues Persistence of leishmania parasites in scars after clinical cure of American cutaneous leishmaniasis: is there a sterile cure? J Infect Dis 189 2004 1018 1023
109. G.W. Wortmann, N.E. Aronson, and R.S. Miller Cutaneous leishmaniasis following local trauma: a clinical pearl Clin Infect Dis 31 2000 199 201
110. B.C. Walton American cutaneous and mucocutaneous leishmaniasis W. Peters K. Killick-Kendrick The leishmaniases in biology and medicine vol 2 1987 Academic Press London 642 644
111. T. Aebischer Recurrent cutaneous leishmaniasis: a role for persistent parasites? Parasitol Today 10 1994 25 28
112. L. Puig, and R. Pradinaud Leishmania and HIV co-infection: dermatological manifestations Ann Trop Med Parasitol 97 Suppl 1 2003 107 114
113. R.N. Sampaio, C.P. Salaro, and P. Resende American cutaneous leishmaniasis associated with HIV/AIDS: report of four clinical cases Rev Soc Bras Med Trop 35 2002 651 654
114. A. Golino, J.M. Duncan, and B. Zeluff Leishmaniasis in a heart transplant patient J Heart Lung Transplant 11 4 Pt 1 1992 820 823
115. A.C. Motta, D. Arruda, and C.S. Souza Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid Int J Dermatol 42 2003 703 706
116. A. Bassiouny, M. El Meshad, and M. Talaat Cryosurgery in cutaneous leishmaniasis Br J Dermatol 107 1982 467 474
117. G.W. Wortmann, N.E. Aronson, and J.C. Byrd Herpes zoster and lymphopenia associated with sodium stibogluconate therapy for cutaneous leishmaniasis Clin Infect Dis 27 1998 509 512
118. P.L. Olliaro, R.G. Ridley, and J. Engel Miltefosine in visceral leishmaniasis Lancet Infect Dis 3 2003 70
119. S. Sundar, T.K. Jha, and C.P. Thakur Oral miltefosine for Indian visceral leishmaniasis N Engl J Med 347 2002 1739 1746
120. J. Soto, J. Toledo, and P. Gutierrez Treatment of American cutaneous leishmaniasis with miltefosine, an oral agent Clin Infect Dis 33 2001 E57 E61
121. J. Soto, B.A. Arana, and J. Toledo Miltefosine for new world cutaneous leishmaniasis Clin Infect Dis 38 2004 1266 1272
122. W.R. Ballou, J.B. McClain, and D.M. Gordon Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis Lancet 2 1987 13 16
123. B.L. Herwaldt, and J.D. Berman Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies Am J Trop Med Hyg 46 1992 296 306
124. B.L. Herwaldt, E.T. Kaye, and T.J. Lepore Sodium stibogluconate (Pentostam) overdose during treatment of American cutaneous leishmaniasis J Infect Dis 165 1992 968 971
125. B.L. Herwaldt Leishmaniasis Lancet 354 1999 1191 1199
126. E.D. Franke, F.S. Wignall, and M.E. Cruz Efficacy and toxicity of sodium stibogluconate for mucosal leishmaniasis Ann Intern Med 113 1990 934 940
127. E.D. Franke, A. Llanos-Cuentas, and J. Echevarria Efficacy of 28-day and 40-day regimens of sodium stibogluconate (Pentostam) in the treatment of mucosal leishmaniasis Am J Trop Med Hyg 51 1994 77 82
128. P.A. Gross, T.L. Barrett, and E.P. Dellinger Purpose of quality standards for infectious diseases. Infectious Diseases Society of America Clin Infect Dis 18 1994 421